MYGN
Myriad Genetics (MYGN) P/E Ratio
P/E Ratio as of Oct 29, 2026: -5.56
Average-4.09
Median-3.62
Minimum-5.56
Maximum-3.32
-5.56
2.03 (57.51%)past month
The P/E ratio for Myriad Genetics (MYGN) is -5.56 as of Oct 29, 2026. This represents a increase of 221.39% compared to its 12-month average P/E ratio of -1.73. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Myriad Genetics P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Myriad Genetics’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Myriad Genetics to industry peers.
Myriad Genetics P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Myriad Genetics’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Myriad Genetics to industry peers.
Myriad Genetics (MYGN) P/E Ratio Insights
See Myriad Genetics’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in Myriad Genetics (MYGN)
Order type
Buy in
Order amount
Est. shares
0 shares
Myriad Genetics (MYGN) P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Oct 1, 2026 | $4.06 | -3.39 |
| Sep 1, 2026 | $3.18 | -2.65 |
| Aug 3, 2026 | $3.02 | -2.52 |
| Jul 1, 2026 | $6.00 | -1.39 |
| Jun 1, 2026 | $4.28 | -0.99 |
| May 1, 2026 | $4.80 | -1.21 |
| Apr 1, 2026 | $4.59 | -1.16 |
| Mar 2, 2026 | $5.01 | -1.27 |
| Feb 2, 2026 | $5.47 | -1.26 |
| Jan 2, 2026 | $6.14 | -1.42 |
Myriad Genetics (MYGN) End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2026 | -5.56 | +291.55% |
| 2025 | -1.42 | -86.54% |
| 2024 | -10.55 | +85.41% |
| 2023 | -5.69 | -62.29% |
| 2022 | -15.09 | -79.56% |
| 2021 | -73.82 | — |
FAQs About Myriad Genetics (MYGN) P/E ratio
The latest P/E ratio of Myriad Genetics (MYGN) is -5.56, as of Oct 29, 2026. This is calculated based on its current stock price and earnings per share (EPS).
Myriad Genetics’s last 12-month average P/E ratio is -1.73, compared to its current P/E ratio of -5.56. This reflects a increase of 221.39%.
Myriad Genetics’s current P/E ratio of -5.56 is higher than its last 12-month average P/E of -1.73. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Myriad Genetics’s average P/E ratio over the last 3 years is -6.09. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Myriad Genetics’s average P/E ratio over the last 5 years is -25.74. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.
Myriad Genetics (MYGN) P/E Ratio Insights
See Myriad Genetics’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in Myriad Genetics (MYGN)
Order type
Buy in
Order amount
Est. shares
0 shares
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.